miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3. (Q39125450)

9 September 2017

miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3. (English)

1 reference

9 September 2017

0 references

1 reference

0 references

Lei Shi

1

1 reference

9 September 2017

Yi Wan

2

1 reference

9 September 2017

Guan Sun

3

1 reference

9 September 2017

Shuguang Zhang

4

1 reference

9 September 2017

Zhimin Wang

5

1 reference

9 September 2017

Yanjun Zeng

6

1 reference

9 September 2017

1 February 2014

1 reference

9 September 2017

1 reference

9 September 2017

28

1 reference

9 September 2017

1

1 reference

9 September 2017

41-54

1 reference

https://scigraph.springernature.com/pub.10.1007/s40259-013-0053-2

9 September 2017

0 references

cites work

High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

MicroRNA-146a inhibits glioma development by targeting Notch1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

Stem cell division is regulated by the microRNA pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

Pharmacogenomics genes show varying perceptibility to microRNA regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

MicroRNAs and pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

Real-time quantification of microRNAs by stem-loop RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

The let-7 microRNA represses cell proliferation pathways in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

21 January 2018

Brain tumour stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

A novel inhibitor of STAT3 homodimerization selectively suppresses STAT3 activity and malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0053-2

10.1007/S40259-013-0053-2

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference